Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – Medical Xpress
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard…
-
General22 hours agoLambie, hypocrisy, and the misinformation & disinformation bill
-
General21 hours agoAFLW Sunday: Chloe Molloy kicks wonder goal as Zippy Fish stars for Swans
-
General22 hours agoDockers coach Justin Longmuir calls for AFL to issue huge fines over staging
-
General23 hours agoNRL live: Raiders rest stars for Dolphins clash, Knights try to avoid wooden spoon against Eels